Morgan Stanley Knock-Out GRMN/ DE000MB6JE72 /
20.05.2024 20:47:04 | Diff.-0,07 | Geld22:00:32 | Brief22:00:32 | Basiswert | Basispreis | Fälligkeit | Optionsart |
---|---|---|---|---|---|---|---|
6,20EUR | -1,12% | - Geld Vol: - |
- Brief Vol: - |
Garmin Ltd | 102,7959 - | 31.12.2078 | Call |
Newsfile Corp
04:49
Tradewave Capital Plc Solidifies Its Position in Financial Markets with Vienna Stock Exchange Listin...
GlobeNewswire
04:38
Stockholder Alert: Robbins LLP Informs Investors that a Class Action Against Teladoc Health, Inc. (T...
Newsfile Corp
04:19
PaleBlueDot Launches $EARTH Token: A Unique Cryptocurrency with a Mission for Global Sustainability
GlobeNewswire
03:00
Volvo Trucks North America and Volvo Financial Services Launch Volvo on Demand to Accelerate Battery...
GlobeNewswire
03:00
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf o...
GlobeNewswire
03:00
GROCERY OUTLET ALERT: Bragar Eagel & Squire, P.C. is Investigating Grocery Outlet Holding Corp. on B...
GlobeNewswire
03:00
VESTIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Again...
GlobeNewswire
02:25
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
GlobeNewswire
02:15
West Coast Community Bancorp and 1st Capital Bancorp Announce Agreement to Merge
GlobeNewswire
02:00
AST Mining Unveils Free Cloud Mining, Paving the Way for Seamless Crypto Investment in 2024.
GlobeNewswire
02:00
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Be...
GlobeNewswire
01:46
Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite